Celltrion Views Brazilian Approval As Gateway Into Latin America

 
• By Aidan Fry
RioDeJaneiro
Celltrion is looking to use its approval for biosimilar trastuzumab in Brazil as a base from whicht to expand in Central and South America • Source: Shutterstock

More from Biosimilars

More from Products